CRISPR screen in regulatory T cells reveals modulators of Foxp3.
Ontology highlight
ABSTRACT: Regulatory T (Treg) cells are required to control immune responses and maintain homeostasis, but are a significant barrier to antitumour immunity1. Conversely, Treg instability, characterized by loss of the master transcription factor Foxp3 and acquisition of proinflammatory properties2, can promote autoimmunity and/or facilitate more effective tumour immunity3,4. A comprehensive understanding of the pathways that regulate Foxp3 could lead to more effective Treg therapies for autoimmune disease and cancer. The availability of new functional genetic tools has enabled the possibility of systematic dissection of the gene regulatory programs that modulate Foxp3 expression. Here we developed a CRISPR-based pooled screening platfo
SUBMITTER: Cortez JT
PROVIDER: S-EPMC7305989 | biostudies-literature | 2020 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA